PCA Investment Advisory Services’s GSK GSK Stock Holding History

PCA Investment Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-226	Closed	-$8.06K	–	237
2023 Q2	$8.06K	Buy	+226	New	+$8.11K	﹤0.01%	410

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCA Investment Advisory Services's GSK Position: Q3 2023 in Review

PCA Investment Advisory Services sold out of GSK (GSK) in Q3 2023, closing a stake of 226 shares — an estimated $8.06K sold.

PCA Investment Advisory Services first reported a position in GSK in Q2 2023 and held it in 1 quarter. The position peaked at $8.06K in Q2 2023. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

PCA Investment Advisory Services reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
PCA Investment Advisory Services sold 226 GSK shares in Q3 2023, an estimated $8.06K.
PCA Investment Advisory Services first reported a position in GSK in Q2 2023 and held it in 1 quarter.
PCA Investment Advisory Services's GSK position peaked at $8.06K in Q2 2023.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.